New Hampshire written opioid-treatment agreements, documented from statute through professional rules

Status: New Hampshire evidence build reviewed through October 4, 2026. This library separates the statutory mandate, professional-board rules, patient protections, current implementation materials, and future practice-specific agreements.

Current legal baseline

RSA 318-B:41 requires New Hampshire’s opioid-prescribing boards to impose mandatory written treatment agreements for chronic-pain opioid treatment. The statute requires the agreements to include conduct that can trigger discontinuation or tapering. The professional rules then define the minimum agreement subjects and related monitoring duties.

Requirement Current New Hampshire framework
Written treatment agreement Mandatory for covered chronic-pain opioid treatment.
Safe medication use/storage Required agreement subject.
Single prescriber/practice Required agreement subject for opioid sourcing.
Drug-testing consent Required agreement subject.
Clinical coverage Required agreement subject; professional rules require 24/7 coverage.
Treatment-plan review At least twice yearly under the current professional rules.
Urine drug testing At least annually for patients using opioids longer than 90 days, subject to narrow exemptions.
PDMP review Initial review and periodic review at least twice yearly, subject to specific exceptions.

State-level records

Multi-profession mandate

RSA 318-B:41 directs opioid-prescribing standards across medicine, dentistry, nursing, optometry, podiatry, and naturopathic practice. Current rules in those professions continue to carry the treatment-agreement framework forward, including recent 2025 and 2026 rule updates.

Patient-protection counterweight

New Hampshire’s statute also protects individualized chronic-pain treatment. It states that opioid care is not to be predetermined by specific MME guidelines; directs continuation of monitored treatment when function and quality of life improve and there is no misuse or diversion; and requires that patients be treated with dignity and not unduly denied needed medication.

Narrow agreement/testing exemptions

The professional rules permit omission of the written agreement and periodic testing for long-term non-rehabilitative nursing-home residents whose medication is administered by licensed staff, and for patients with episodic intermittent pain receiving no more than 50 opioid dose units in a three-month period.

Current state implementation record

New Hampshire’s Office of Professional Licensure and Certification publishes a prescriber checklist identifying the Written Treatment Agreement, twice-yearly treatment review, at-least-twice-yearly PDMP review, annual urine testing after 90 days, and the narrow exemptions.

2026 access reform

Chapter 282, enacted July 10, 2026, requires health carriers beginning January 1, 2027 to create broader chronic-pain management programs with access to non-opioid and non-medication services and limits use of prior authorization merely to access the program. That reform does not repeal the written-agreement mandate.

Practice-specific evidence gap

The current public search found strong statutory, regulatory, and state implementation evidence but fewer reliable current clinic-specific New Hampshire opioid agreements than in several earlier states. This library does not fill that gap with generic national forms or stale documents. Practice agreements will be added when current New Hampshire use can be verified.

Formal change route

The core mandate is in RSA 318-B:41(c)(1), so removing it requires statutory amendment through the New Hampshire General Court. Current health-policy gatekeepers include Senate Health and Human Services Chair David Rochefort and House Health, Human Services and Elderly Affairs Chair Wayne MacDonald. Separate rule petitions under RSA 541-A:4 may seek changes to implementing rules, but boards cannot override the statutory requirement.

Submit a missing New Hampshire agreement

Submit a New Hampshire Contract for Care

Primary authorities

Reviewed: October 4, 2026.

Evidence boundary: New Hampshire’s written-agreement mandate is statutory and professional-regulatory. State implementation tools, future insurance reforms, and clinic-added terms remain distinct evidence layers.